alanine has been researched along with organophosphonates in 57 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 11 (19.30) | 18.7374 |
1990's | 5 (8.77) | 18.2507 |
2000's | 19 (33.33) | 29.6817 |
2010's | 18 (31.58) | 24.3611 |
2020's | 4 (7.02) | 2.80 |
Authors | Studies |
---|---|
Horigane, A; Horiguchi, M; Matsumoto, T | 1 |
Allen, JG; Atherton, FR; Hall, MJ; Hassall, CH; Holmes, SW; Lambert, RW; Nisbet, LJ; Ringrose, PS | 1 |
Gilmore, F; Huber, JW; Robertson, LW | 1 |
Jacobsen, JR; Kochersperger, L; Prudent, JR; Schultz, PG; Yonkovich, S | 1 |
Duncan, K; Walsh, CT | 1 |
Atherton, FR; Hassall, CH; Lambert, RW | 1 |
Lacoste, AM; Neuzil, E | 1 |
Roop, BL; Roop, WE; Tan, SA | 1 |
Law, JH; Smith, JD | 1 |
Diller, A; Schirch, LV | 1 |
Bleiweis, AS; Krause, RM; Young, FE | 1 |
Grünberger, D; Holý, A; Smrt, J; Sorm, F | 1 |
Biggs, CS; Fowler, LJ; Maione, S; Whitton, PS | 1 |
Bushell, TJ; Collingridge, GL; Garthwaite, J; Jane, DE; Tse, HW; Watkins, JC | 1 |
Breyne, O; Carillon, S; Marquet, A; Ploux, O | 1 |
Erni, B; Reymond, JL; Schenkels, C | 1 |
Cihlar, T; Ho, ES; Lin, DC; Mendel, DB | 1 |
Bearne, SL; St Maurice, M | 1 |
Ballatore, C; Balzarini, J; De Clercq, E; McGuigan, C | 1 |
Berman, HA; Kovarik, Z; Radić, Z; Reiner, E; Simeon-Rudolf, V; Taylor, P | 1 |
Clark, T; Lanig, H; Schürer, G | 1 |
Cole, PA; Klein, DC; Lebeau, A; Schwarzer, D; Weller, JL; Zheng, W | 1 |
Cihlar, T; Cundy, KC; Eisenberg, E; He, GX; Lee, WA; Mulato, A; Swaminathan, S | 1 |
Dang, Q; Erion, MD; Jiang, T; Kasibhatla, SR; Lipscomb, WN; Potter, SC; Reddy, KR; Reddy, MR; van Poelje, PD | 1 |
Chandramouli, VC; Dang, Q; Erion, MD; Landau, BR; Potter, SC; van Poelje, PD | 1 |
Bischofberger, N; Blackwood, EJ; Colón, R; Kearney, BP; Lawson, JR; Lee, WA; Marthas, ML; Sexton, JJ; Van Rompay, KK | 1 |
Tomlinson, B; Wang, Y | 1 |
Antipin, IS; Danila, DC; Hubble, H; Pinkhassik, E; Wang, X | 1 |
Birkus, G; Cihlar, T; He, GX; Kutty, N; Lee, W; McDermott, M; Mulato, A | 1 |
Holý, A; Otová, B; Votruba, I | 1 |
Hrabálek, A; Janůsová, B; Kovaríková, P; Novotný, J; Novotný, M; Vávrová, K | 1 |
Fujiwara, T; Hagisawa, Y; Izumi, M; Ohsumi, J; Okuno, A; Takahashi, K; Yoshida, T | 1 |
Cole, PA; Szewczuk, LM; Tarrant, MK | 1 |
Fujiwara, T; Hagisawa, Y; Kanda, S; Nakashima, R; Ogawa, J; Okuno, A; Takahashi, K; Tanaka, J; Yoshida, T | 1 |
Chen, TY; Guga, P; Jayaram, M; Kachroo, AH; Ma, CH; Macieszak, A | 1 |
Nishi, T; Okuno, A; Shiiki, T; Takagi, T; Takahashi, M; Tamaki, K; Tanaka, J; Tsukada, T; Yoshida, T | 1 |
Lu, J; Xie, Z; Zhang, H; Zhang, WJ; Zhang, Y; Zhou, G | 1 |
Froeyen, M; Herdewijn, P; Lescrinier, E; Marlière, P; Yang, S | 1 |
Cashion, DK; Dang, Q; DaRe, J; Erion, MD; Fan, Y; Gibson, T; Jacintho, JD; Jiang, T; Kasibhatla, SR; Lemus, R; Li, H; Li, W; Liu, Y; Potter, SC; Sun, Z; Taplin, F; Tian, F; van Poelje, PD | 1 |
Fujiwara, T; Hagisawa, Y; Kanda, S; Ogawa, J; Okuno, A; Takahashi, K; Yoshida, T | 1 |
Carrothers, TJ; Habtemariam, B; Kastrissios, H; Khariton, T; Kshirsagar, S; Mager, DE; Rohatagi, S; Walker, JR | 1 |
Erion, MD; Potter, SC; van Poelje, PD | 1 |
Borysko, K; Breitenbach, J; Drach, JC; Hilfinger, J; Kashemirov, BA; Kijek, P; Kim, JS; McKenna, CE; Mitchell, S; Peterson, LW | 1 |
Attwood, PV; Besant, PG; Byrne, LT; Flematti, GR; Mukai, S; Piggott, MJ | 1 |
Berger, D; Bredeek, UF; Callebaut, C; DeJesus, E; Fordyce, MW; Markowitz, M; Ramanathan, S; Rhee, MS; Ruane, PJ; Yale, K; Zhong, L | 1 |
Callebaut, C; Cao, H; Cheng, A; Crofoot, G; Custodio, J; Das, M; Flamm, JA; Gathe, J; Liu, HC; Martin, H; McCallister, S; McDonald, C; Mills, A; Saag, M; Scribner, A; Shalit, P; Shamblaw, D; Thomas, A; Yan, M | 1 |
Baeten, JM; Wyatt, C | 1 |
Andrade-Villanueva, J; Callebaut, C; Cao, H; Cheng, AK; Crofoot, G; Custodio, JM; DeJesus, E; Fordyce, MW; Koenig, E; Martin, H; McCallister, S; Molina, JM; Oka, S; Plummer, A; Podzamczer, D; Post, F; Pozniak, A; Saag, M; Sax, PE; Thompson, M; Trottier, B; Wohl, D; Yin, MT; Zhong, L | 1 |
Beraud, G; Chagneau-Derrode, C; Garcia, M; Godet, C; Le Moal, G; Roblot, F | 1 |
Ensign, LM; Hoang, T; Hummert, P; Marzinke, MA; Parsons, TL | 1 |
Bensouda, S; Cone, RA; Date, AA; Ensign, LM; Fuchs, EJ; Gumber, S; Hanes, J; Hendrix, C; Hoang, T; Marzinke, M; Ortiz, JO; Rohan, L; Villinger, F; Xiao, P; Young, TW | 1 |
de la Cruz, F; Giner-Robles, L; Lázaro, B; Moncalián, G | 1 |
Hiraoka, A; Izumoto, H; Kitahata, S; Kondoh, K; Michitaka, K; Ninomiya, T; Tsubouchi, E; Ueki, H; Yamago, H | 1 |
Hooi, B; Leungsuwan, S; Myint, KS | 1 |
Ju, KS; Kayrouz, CM; Pham, TM; Zhang, Y | 1 |
Asmuth, DM; Baeten, JM; Brainard, DM; Brunetta, JM; Carter, C; Cox, S; Das, M; Ebrahimi, R; Gilson, R; Henry, K; Kintu, A; Kronborg, G; Ogbuagu, O; Podzamczer, D; Ruane, PJ; Salazar, LC; Shao, Y; Spinner, CD; Whitlock, G; Wohl, D | 1 |
Ahn, SH; Jung, CY; Kim, BS; Kim, HW; Kim, SU; Lee, HW; Lee, JI | 1 |
3 review(s) available for alanine and organophosphonates
Article | Year |
---|---|
Managlinat dialanetil, a fructose-1,6-bisphosphatase inhibitor for the treatment of type 2 diabetes.
Topics: Alanine; Animals; Diabetes Mellitus, Type 2; Drug Evaluation, Preclinical; Fructose-Bisphosphatase; Humans; Hypoglycemic Agents; Organophosphonates; Organophosphorus Compounds; Structure-Activity Relationship | 2007 |
[Acyclic nucleoside phosphonates as potential antineoplastic agents].
Topics: Adenine; Alanine; Animals; Antineoplastic Agents; Cell Line, Tumor; Guanine; Humans; Lymphoma, Non-Hodgkin; Nucleosides; Organophosphonates; Organophosphorus Compounds; Purines | 2008 |
Fructose-1, 6-bisphosphatase inhibitors for reducing excessive endogenous glucose production in type 2 diabetes.
Topics: Alanine; Animals; Diabetes Mellitus, Type 2; Enzyme Inhibitors; Fructose-Bisphosphatase; Gluconeogenesis; Glucose; Humans; Hypoglycemic Agents; Organophosphonates; Organophosphorus Compounds; Signal Transduction | 2011 |
4 trial(s) available for alanine and organophosphonates
Article | Year |
---|---|
Antiviral activity, safety, and pharmacokinetics/pharmacodynamics of tenofovir alafenamide as 10-day monotherapy in HIV-1-positive adults.
Topics: Adenine; Adult; Alanine; Anti-Retroviral Agents; Area Under Curve; Dose-Response Relationship, Drug; Fatigue; Female; HIV Infections; HIV-1; Humans; Male; Middle Aged; Nausea; Organophosphates; Organophosphonates; RNA, Viral; Single-Blind Method; Statistics, Nonparametric; Tenofovir; Viral Load; Young Adult | 2013 |
Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate in the First Protease Inhibitor-Based Single-Tablet Regimen for Initial HIV-1 Therapy: A Randomized Phase 2 Study.
Topics: Adenine; Adult; Alanine; Anti-HIV Agents; Female; HIV Infections; HIV-1; Humans; Male; Organophosphonates; RNA, Viral; Tenofovir | 2015 |
Tenofovir alafenamide versus tenofovir disoproxil fumarate, coformulated with elvitegravir, cobicistat, and emtricitabine, for initial treatment of HIV-1 infection: two randomised, double-blind, phase 3, non-inferiority trials.
Topics: Adenine; Adult; Alanine; Anti-HIV Agents; Arthralgia; Bone Density; Carbamates; CD4 Lymphocyte Count; Cobicistat; Deoxycytidine; Double-Blind Method; Drug Combinations; Emtricitabine; Female; Headache; HIV Infections; Humans; Kidney; Male; Nausea; Organophosphonates; Quinolones; Respiration Disorders; Sleep Initiation and Maintenance Disorders; Tenofovir; Thiazoles; Treatment Outcome; Viral Load | 2015 |
Long-term safety and efficacy of emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV-1 pre-exposure prophylaxis: week 96 results from a randomised, double-blind, placebo-controlled, phase 3 trial.
Topics: Adenine; Adult; Aged; Alanine; Anti-HIV Agents; Double-Blind Method; Drug Therapy, Combination; Emtricitabine; Female; Follow-Up Studies; HIV Infections; HIV-1; Humans; Male; Middle Aged; Organophosphonates; Pre-Exposure Prophylaxis; Tenofovir; Treatment Outcome; Young Adult | 2021 |
50 other study(ies) available for alanine and organophosphonates
Article | Year |
---|---|
Metabolism of 2-amino-3-phosphono[3-14C]propionic acid in cell-free preparations of rat liver.
Topics: Alanine; Amino Acids; Animals; Cell-Free System; Liver; Organophosphonates; Organophosphorus Compounds; Phosphoenolpyruvate; Pyruvates; Rats | 1979 |
Phosphonopeptides, a new class of synthetic antibacterial agents.
Topics: Alanine; Alanine Racemase; Animals; Anti-Bacterial Agents; Bacteria; Cell Wall; Dipeptides; Humans; Membrane Transport Proteins; Microbial Sensitivity Tests; Organophosphonates; Organophosphorus Compounds; Structure-Activity Relationship | 1978 |
Synthesis and antimicrobial evaluation of N-D-alanyl-1-aminoethylphosphonic acid.
Topics: Alanine; Anti-Bacterial Agents; Anti-Infective Agents; Aspergillus; Bacillus subtilis; Candida albicans; Escherichia coli; Ethylamines; Microbial Sensitivity Tests; Mycobacterium; Organophosphonates; Organophosphorus Compounds; Proteus vulgaris; Pseudomonas aeruginosa; Saccharomyces cerevisiae; Staphylococcus; Trichophyton | 1975 |
An efficient antibody-catalyzed aminoacylation reaction.
Topics: Acylation; Alanine; Amino Acyl-tRNA Synthetases; Antibodies, Monoclonal; Catalysis; Chromatography, High Pressure Liquid; Esterification; Haptens; Hemocyanins; Kinetics; Organophosphonates; Serum Albumin, Bovine; Thymidine | 1992 |
ATP-dependent inactivation and slow binding inhibition of Salmonella typhimurium D-alanine:D-alanine ligase (ADP) by (aminoalkyl)phosphinate and aminophosphonate analogues of D-alanine.
Topics: Alanine; Binding, Competitive; Kinetics; Mathematics; Organophosphonates; Peptide Synthases; Phosphinic Acids; Protein Binding; Salmonella typhimurium; Structure-Activity Relationship | 1988 |
Synthesis and structure-activity relationships of antibacterial phosphonopeptides incorporating (1-aminoethyl)phosphonic acid and (aminomethyl)phosphonic acid.
Topics: Alanine; Aminoethylphosphonic Acid; Animals; Anti-Bacterial Agents; Bacteria; Biological Transport, Active; Chemical Phenomena; Chemistry; Escherichia coli; Escherichia coli Infections; Haemophilus influenzae; Mice; Organophosphonates; Organophosphorus Compounds; Peptides; Streptococcus; Structure-Activity Relationship | 1986 |
[Transamination of 2-aminoethylphosphonic acid by Pseudomonas aeruginosa].
Topics: Alanine; Amino Acids; Chromatography, Paper; Organophosphonates; Pseudomonas aeruginosa | 1969 |
Detection of aminoalkylphosphonates with a ninhydrin-molybdate chromogenic system.
Topics: Alanine; Aniline Compounds; Chemical Phenomena; Chemistry; Chlorine; Colorimetry; Densitometry; Indenes; Indicators and Reagents; Ketones; Methods; Molybdenum; Organophosphonates; Phenols; Sulfites | 1971 |
Phosphonic acid metabolism in Tetrahymena.
Topics: Alanine; Amino Acids; Animals; Carbon Isotopes; Chloroform; Chromatography, Gas; Chromatography, Paper; Chromatography, Thin Layer; Ethers; Fatty Acids; Glycerides; Hydrogen-Ion Concentration; Methanol; Organophosphonates; Phospholipids; Solubility; Tetrahymena | 1970 |
Serine transhydroxymethylase. Affinity of the active site for substrates, substrate analogues, and anions.
Topics: Alanine; Aldehydes; Aminoisobutyric Acids; Animals; Benzoates; Binding Sites; Chlorides; Cysteamine; Cysteine; Electrophoresis; Folic Acid; Glycine; Hot Temperature; Hydrogen-Ion Concentration; Kinetics; Mercaptoethanol; Models, Biological; Organophosphonates; Phosphates; Potassium; Propionates; Pyridoxal Phosphate; Rabbits; Serine; Spectrophotometry; Stereoisomerism; Sulfates; Sulfhydryl Compounds; Sulfonic Acids; Thermodynamics; Threonine; Transferases; Ultracentrifugation | 1971 |
Cell walls of group D streptococci. II. Chemical studies on the type 1 antigen purified from the autolytic digest of cell walls.
Topics: Alanine; Ammonia; Antigens; Bacteriolysis; Cell Wall; Chromatography, Gas; Chromatography, Gel; Chromatography, Ion Exchange; Electrophoresis; Glucosamine; Glucose; Glutamates; Hexosamines; Lysine; Organophosphonates; Phosphorus; Precipitin Tests; Rhamnose; Ribose; Streptococcus; Ultracentrifugation | 1967 |
Synthesis of a GpUpU analogue containing 5'-deoxyuridine 5'-phosphonic acid and its effect upon the binding of [14C]valyl- and [14C]alanyl-tRNA to ribosomes.
Topics: Alanine; Animals; Carbon Isotopes; Genetic Code; Organophosphonates; Ribosomes; RNA, Transfer; Snakes; Uracil Nucleotides; Valine; Venoms | 1967 |
N-methyl-d-aspartate receptors modulate extracellular dopamine concentration and metabolism in rat hippocampus and striatum in vivo.
Topics: 3,4-Dihydroxyphenylacetic Acid; Alanine; Animals; Corpus Striatum; Dopamine; Hippocampus; Homovanillic Acid; Male; Microdialysis; N-Methylaspartate; Organophosphonates; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate | 1994 |
Pharmacological antagonism of the actions of group II and III mGluR agonists in the lateral perforant path of rat hippocampal slices.
Topics: 2-Chloroadenosine; Alanine; Aminobutyrates; Animals; Animals, Newborn; Cycloleucine; Depression, Chemical; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Hippocampus; Organophosphonates; Rats; Receptors, Metabotropic Glutamate; Synaptic Transmission; Tetrazoles | 1996 |
Slow-binding and competitive inhibition of 8-amino-7-oxopelargonate synthase, a pyridoxal-5'-phosphate-dependent enzyme involved in biotin biosynthesis, by substrate and intermediate analogs. Kinetic and binding studies.
Topics: Acyl Coenzyme A; Acyltransferases; Alanine; Aldehydes; Aminoethylphosphonic Acid; Biotin; Catalytic Domain; Dose-Response Relationship, Drug; Imines; Kinetics; Models, Chemical; Organophosphonates; Protein Conformation; Pyridoxal Phosphate; Stereoisomerism | 1999 |
Phosphofurylalanine, a stable analog of phosphohistidine.
Topics: Alanine; Histidine; Models, Molecular; Organophosphonates; Stereoisomerism | 1999 |
Cytotoxicity of antiviral nucleotides adefovir and cidofovir is induced by the expression of human renal organic anion transporter 1.
Topics: Adenine; Alanine; Animals; Anion Transport Proteins; Antiviral Agents; Biological Transport; Carrier Proteins; CHO Cells; Cidofovir; Cricetinae; Cytosine; Humans; Kidney; Organophosphate Poisoning; Organophosphonates; Organophosphorus Compounds; Probenecid | 2000 |
Reaction intermediate analogues for mandelate racemase: interaction between Asn 197 and the alpha-hydroxyl of the substrate promotes catalysis.
Topics: Alanine; Amino Acid Sequence; Asparagine; Binding Sites; Carboxylic Acids; Catalysis; Kinetics; Mandelic Acids; Molecular Sequence Data; Mutagenesis, Site-Directed; Organophosphonates; Protons; Pseudomonas putida; Racemases and Epimerases; Static Electricity; Stereoisomerism; Substrate Specificity | 2000 |
Synthesis and evaluation of novel amidate prodrugs of PMEA and PMPA.
Topics: Adenine; Alanine; Amides; Antiviral Agents; Drug Stability; Esterases; Humans; Nucleotides; Organophosphonates; Organophosphorus Compounds; Phosphoric Acids; Prodrugs; Retroviridae; Structure-Activity Relationship; Tenofovir | 2001 |
Mutant cholinesterases possessing enhanced capacity for reactivation of their phosphonylated conjugates.
Topics: Acetylcholinesterase; Alanine; Amino Acid Substitution; Animals; Butyrylcholinesterase; Cholinesterase Reactivators; Computer Simulation; Kinetics; Mice; Models, Molecular; Mutation; Organophosphonates; Organophosphorus Compounds; Oximes; Pralidoxime Compounds; Pyridinium Compounds; Structure-Activity Relationship; Tyrosine | 2004 |
Aeromonas proteolytica aminopeptidase: an investigation of the mode of action using a quantum mechanical/molecular mechanical approach.
Topics: Aeromonas; Alanine; Aminopeptidases; Animals; Bacterial Proteins; Binding Sites; Catalysis; Cations, Divalent; Cattle; Computers, Molecular; Enzyme Activation; Enzyme Inhibitors; Enzyme Stability; Hydrogen Bonding; Hydrolysis; Hydroxides; Leucine; Models, Chemical; Models, Molecular; Organophosphonates; Static Electricity; Substrate Specificity; Zinc | 2004 |
Cellular stability of serotonin N-acetyltransferase conferred by phosphonodifluoromethylene alanine (Pfa) substitution for Ser-205.
Topics: 14-3-3 Proteins; Alanine; Amino Acids; Animals; Arylalkylamine N-Acetyltransferase; CHO Cells; Cloning, Molecular; Cricetinae; DNA, Complementary; Electrophoresis, Polyacrylamide Gel; Hydrocarbons; Immunohistochemistry; Kinetics; Mass Spectrometry; Melatonin; Methane; Models, Biological; Models, Chemical; Organophosphonates; Peptides; Phosphorylation; Protein Binding; Protein Processing, Post-Translational; Protein Structure, Tertiary; Proteins; Serine; Sheep | 2005 |
Selective intracellular activation of a novel prodrug of the human immunodeficiency virus reverse transcriptase inhibitor tenofovir leads to preferential distribution and accumulation in lymphatic tissue.
Topics: Adenine; Alanine; Animals; Anti-HIV Agents; Area Under Curve; CD4-Positive T-Lymphocytes; Chromatography, High Pressure Liquid; Dogs; HIV-1; Humans; In Vitro Techniques; Lymphatic System; Male; Organophosphonates; Prodrugs; Reverse Transcriptase Inhibitors; Spectrophotometry, Ultraviolet; Tenofovir; Tissue Distribution | 2005 |
MB06322 (CS-917): A potent and selective inhibitor of fructose 1,6-bisphosphatase for controlling gluconeogenesis in type 2 diabetes.
Topics: Adenosine Monophosphate; Alanine; Analysis of Variance; Animals; Carbon Radioisotopes; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Drug Design; Fructose-Bisphosphatase; Gluconeogenesis; Humans; Liver; Male; Molecular Mimicry; Organophosphonates; Organophosphorus Compounds; Rats; Rats, Sprague-Dawley; Rats, Zucker; Spectrophotometry; Thiazoles | 2005 |
Inhibition of fructose 1,6-bisphosphatase reduces excessive endogenous glucose production and attenuates hyperglycemia in Zucker diabetic fatty rats.
Topics: Alanine; Animals; Blood Glucose; Body Weight; Cholesterol; Diabetes Mellitus, Type 2; Eating; Female; Fructose-Bisphosphatase; Gluconeogenesis; Glucose; Hyperglycemia; Insulin; Ketone Bodies; Lactic Acid; Male; Molecular Structure; Organophosphonates; Organophosphorus Compounds; Pancreas; Rats; Rats, Zucker; Triglycerides | 2006 |
Evaluation of oral tenofovir disoproxil fumarate and topical tenofovir GS-7340 to protect infant macaques against repeated oral challenges with virulent simian immunodeficiency virus.
Topics: Adenine; Administration, Oral; Administration, Topical; Alanine; Animals; Anti-HIV Agents; Genetic Predisposition to Disease; Macaca mulatta; Organophosphonates; Prodrugs; Simian Acquired Immunodeficiency Syndrome; Simian Immunodeficiency Virus; Tenofovir; Virulence | 2006 |
Increasing permeability of phospholipid bilayer membranes to alanine with synthetic alpha-aminophosphonate carriers.
Topics: Alanine; Biological Transport; Cell Membrane Permeability; Delayed-Action Preparations; Drug Carriers; Lipid Bilayers; Organophosphonates; Phospholipids | 2008 |
Activation of 9-[(R)-2-[[(S)-[[(S)-1-(Isopropoxycarbonyl)ethyl]amino] phenoxyphosphinyl]-methoxy]propyl]adenine (GS-7340) and other tenofovir phosphonoamidate prodrugs by human proteases.
Topics: Adenine; Alanine; Anti-HIV Agents; beta-N-Acetylhexosaminidases; Biomarkers; Cathepsin A; Cells, Cultured; Enzyme Activation; Humans; Hydrolysis; Kinetics; Leukocytes, Mononuclear; Lysosomes; Molecular Structure; Organophosphonates; Peptide Hydrolases; Prodrugs; Reverse Transcriptase Inhibitors; Serine Endopeptidases; Subcellular Fractions; Substrate Specificity; Tenofovir | 2008 |
Dimethylamino acid esters as biodegradable and reversible transdermal permeation enhancers: effects of linking chain length, chirality and polyfluorination.
Topics: Adenine; Administration, Cutaneous; Alanine; Animals; Caproates; Chemistry, Pharmaceutical; Dimethylamines; Dodecanol; Drug Carriers; Drug Compounding; Drug Stability; Electric Impedance; Esterases; Halogenation; Hydrocortisone; Hydrolysis; Indomethacin; Isomerism; Methylamines; Molecular Structure; Organophosphonates; Skin; Skin Absorption; Structure-Activity Relationship; Swine; Theophylline; Time Factors | 2009 |
CS-917, a fructose 1,6-bisphosphatase inhibitor, improves postprandial hyperglycemia after meal loading in non-obese type 2 diabetic Goto-Kakizaki rats.
Topics: Alanine; Animals; Blood Glucose; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Drug Administration Schedule; Enzyme Inhibitors; Fructose-Bisphosphatase; Fructosediphosphates; Fructosephosphates; Gluconeogenesis; Hyperglycemia; Liver; Male; Organophosphonates; Organophosphorus Compounds; Rats; Rats, Wistar | 2008 |
Protein phosphorylation by semisynthesis: from paper to practice.
Topics: Alanine; Animals; Humans; Inteins; Organophosphonates; Phenylalanine; Phosphoamino Acids; Phosphopeptides; Phosphoproteins; Phosphorylation; Phosphoserine; Phosphothreonine; Recombinant Fusion Proteins | 2009 |
Metformin primarily decreases plasma glucose not by gluconeogenesis suppression but by activating glucose utilization in a non-obese type 2 diabetes Goto-Kakizaki rats.
Topics: Alanine; Animals; Blood Glucose; Cells, Cultured; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Fructose-Bisphosphatase; Gluconeogenesis; Glucose; Hepatocytes; Hypoglycemic Agents; Inhibitory Concentration 50; Insulin; Lactic Acid; Male; Metformin; Organophosphonates; Organophosphorus Compounds; Radioisotope Dilution Technique; Rats; Rats, Mutant Strains; Rats, Wistar | 2009 |
Reactions of Cre with methylphosphonate DNA: similarities and contrasts with Flp and vaccinia topoisomerase.
Topics: Alanine; Arginine; Catalytic Domain; DNA; DNA Nucleotidyltransferases; DNA Topoisomerases; Escherichia coli; Genetic Variation; Hydrolysis; Integrases; Models, Biological; Organophosphonates; Static Electricity; Tyrosine; Vaccinia virus | 2009 |
A prodrug approach towards the development of tricyclic-based FBPase inhibitors.
Topics: Alanine; Animals; Cells, Cultured; Crystallography, X-Ray; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Design; Enzyme Inhibitors; Haplorhini; Molecular Conformation; Organophosphonates; Prodrugs; Pyridines; Structure-Activity Relationship; Thiazoles | 2010 |
Fructose-1,6-bisphosphatase regulates glucose-stimulated insulin secretion of mouse pancreatic beta-cells.
Topics: Alanine; Animals; Cells, Cultured; Diabetes Mellitus, Type 2; Enzyme Inhibitors; Fructose-Bisphosphatase; Gene Knockdown Techniques; Glucose; Insulin; Insulin Secretion; Insulin-Secreting Cells; Mice; Mice, Inbred C57BL; Organophosphonates; Organophosphorus Compounds; RNA, Small Interfering; Thiazoles; Transfection; Up-Regulation | 2010 |
3-Phosphono-L-alanine as pyrophosphate mimic for DNA synthesis using HIV-1 reverse transcriptase.
Topics: Alanine; Biomimetic Materials; DNA; HIV Reverse Transcriptase; Kinetics; Models, Molecular; Molecular Structure; Organophosphonates; Phosphoric Acids | 2011 |
Discovery of a series of phosphonic acid-containing thiazoles and orally bioavailable diamide prodrugs that lower glucose in diabetic animals through inhibition of fructose-1,6-bisphosphatase.
Topics: Administration, Oral; Alanine; Amides; Animals; Biological Availability; Blood Proteins; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Fructose-Bisphosphatase; Humans; Hypoglycemic Agents; Male; Mice; Organophosphonates; Prodrugs; Protein Binding; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship; Thiazoles | 2011 |
Contributions of hepatic gluconeogenesis suppression and compensative glycogenolysis on the glucose-lowering effect of CS-917, a fructose 1,6-bisphosphatase inhibitor, in non-obese type 2 diabetes Goto-Kakizaki rats.
Topics: Alanine; Amides; Animals; Blood Glucose; Diabetes Mellitus, Type 2; Drug Evaluation, Preclinical; Fasting; Gluconeogenesis; Glucose; Glycogenolysis; Hypoglycemic Agents; Indoles; Lactic Acid; Male; Organophosphonates; Organophosphorus Compounds; Peptide Hydrolases; Rats | 2011 |
Population pharmacokinetic model for a novel oral hypoglycemic formed in vivo: comparing the use of active metabolite data alone versus using data of upstream and downstream metabolites.
Topics: Aged; Alanine; Computer Simulation; Female; Humans; Hypoglycemic Agents; Male; Middle Aged; Models, Biological; Molecular Structure; Organophosphonates; Prodrugs; Thiazoles | 2012 |
Synthesis, transport and antiviral activity of Ala-Ser and Val-Ser prodrugs of cidofovir.
Topics: Administration, Oral; Alanine; Animals; Antiviral Agents; Cells, Cultured; Cidofovir; Cytomegalovirus; Cytosine; Disease Models, Animal; Dose-Response Relationship, Drug; Humans; Inhibitory Concentration 50; Molecular Structure; Organophosphonates; Peptides; Prodrugs; Rats; Serine; Valine | 2011 |
Stable triazolylphosphonate analogues of phosphohistidine.
Topics: Alanine; Amino Acids; Catalysis; Chromatography, High Pressure Liquid; Click Chemistry; Copper; Fluorenes; Haptens; Histidine; Organophosphonates; Stereoisomerism; Triazoles | 2012 |
Tenofovir alafenamide for HIV infection: is less more?
Topics: Adenine; Alanine; Anti-HIV Agents; Carbamates; Cobicistat; Deoxycytidine; Emtricitabine; Female; HIV Infections; Humans; Male; Organophosphonates; Quinolones; Tenofovir; Thiazoles | 2015 |
First case report of renal improvement on tenofovir alafenamide in an HIV/hepatitis B virus-coinfected patient with adefovir-induced Fanconi's syndrome.
Topics: Absorptiometry, Photon; Adenine; Alanine; Coinfection; Dose-Response Relationship, Drug; Fanconi Syndrome; Hepatitis B, Chronic; HIV Infections; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Organophosphonates; Tenofovir; Treatment Outcome | 2016 |
Validation and implementation of liquid chromatographic-mass spectrometric (LC-MS) methods for the quantification of tenofovir prodrugs.
Topics: Adenine; Alanine; Anti-HIV Agents; Chromatography, Liquid; Humans; Organophosphonates; Prodrugs; Tandem Mass Spectrometry; Tenofovir | 2018 |
Development of rectal enema as microbicide (DREAM): Preclinical progressive selection of a tenofovir prodrug enema.
Topics: Adenine; Administration, Rectal; Alanine; Animals; Anti-HIV Agents; Anti-Infective Agents; Enema; HIV Infections; HIV-1; Homosexuality, Male; Male; Mice; Organophosphates; Organophosphonates; Pre-Exposure Prophylaxis; Prodrugs; Rectum; Sexual and Gender Minorities; Tenofovir | 2019 |
fabH deletion increases DHA production in Escherichia coli expressing Pfa genes.
Topics: Alanine; Amino Acids; Boronic Acids; Cerulenin; Docosahexaenoic Acids; Escherichia coli; Fatty Acids; Gene Expression; Organophosphonates | 2018 |
[Marked improvement in renal tubular markers after switching from adefovir to tenofovir alafenamide in a case of Fanconi syndrome diagnosed through high ALP levels].
Topics: Adenine; Alanine; Alkaline Phosphatase; Antiviral Agents; Biomarkers; DNA, Viral; Drug Resistance, Viral; Drug Therapy, Combination; Fanconi Syndrome; Female; Hepatitis B virus; Hepatitis B, Chronic; Humans; Middle Aged; Organophosphonates; Tenofovir; Tomography, X-Ray Computed; Treatment Outcome | 2019 |
Hypophosphatemic Osteomalacia Due to Adefovir-Induced Fanconi Syndrome.
Topics: Adenine; Aged; Alanine; Antiviral Agents; Fanconi Syndrome; Female; Hepatitis C, Chronic; Humans; Hypophosphatemia; Organophosphonates; Osteomalacia; Tenofovir | 2020 |
Genome Mining Reveals the Phosphonoalamide Natural Products and a New Route in Phosphonic Acid Biosynthesis.
Topics: Alanine; Anti-Bacterial Agents; Bacteria; Genome, Bacterial; Genomics; Microbial Sensitivity Tests; Multigene Family; Organophosphonates; Peptides; Pyruvates | 2020 |
Similar risk of kidney function decline between tenofovir alafenamide and besifovir dipivoxil maleate in chronic hepatitis B.
Topics: Adenine; Alanine; Antiviral Agents; Guanine; Hepatitis B; Hepatitis B, Chronic; Humans; Kidney; Longitudinal Studies; Maleates; Organophosphonates; Renal Insufficiency, Chronic; Retrospective Studies; Tenofovir; Treatment Outcome | 2022 |